RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer

Archive ouverte

Schneider, Anne, T | Gautheron, Jérémie | Feoktistova, Maria | Roderburg, Christoph | Loosen, Sven, H | Roy, Sanchari | Benz, Fabian | Schemmer, Peter | Büchler, Markus, W | Nachbur, Ueli | Neumann, Ulf, P | Tolba, Rene | Luedde, Mark | Zucman-Rossi, Jessica | Panayotova-Dimitrova, Diana | Leverkus, Martin | Preisinger, Christian | Tacke, Frank | Trautwein, Christian | Longerich, Thomas | Vucur, Mihael | Luedde, Tom

Edité par CCSD ; Elsevier -

International audience. Highlights d RIPK1 ablation induces TNF-mediated hepatocyte apoptosis without affecting NF-kB d Loss of RIPK1 leads to proteasomal TRAF2 degradation in a kinase-independent manner d RIPK1 and TRAF2 act together to prevent spontaneous HCC development d Low expression of TRAF2 and RIPK1 in human HCC predicts poor prognosis

Suggestions

Du même auteur

The enigma of RIPK1 in the liver: More than just a kinase

Archive ouverte | Vucur, Mihael | CCSD

International audience. Receptor interacting protein kinase 1 (RIPK1) represents a key molecule in cell death. Here, we discuss our recent data on RIPK1 in liver injury and hepatocellular carcinoma development and p...

The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance

Archive ouverte | Gautheron, Jérémie | CCSD

International audience. Receptor-interacting protein kinase 3 (RIPK3) mediates necroptosis, a form of programmed cell death that promotes inflammation in various pathological conditions, suggesting that it might be ...

miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib

Archive ouverte | Roy, Sanchari | CCSD

International audience

Chargement des enrichissements...